News

Press ReleaseCell and Gene Therapy Catapult invests in Lir Therapeutics to accelerate development of its AI-driven AAV design platform
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Press release: Cell Medica acquisition of WT1 T-cell therapyPress release: Cell Medica acquisition of WT1 T-cell therapyConstructing the Cell and Gene Therapy Catapult manufacturing centreConstructing the Cell and Gene Therapy Catapult manufacturing centrePress release: Cell and Gene Therapy Catapult Licenses Cell Culture Data to Ajinomoto Co., Inc.Press release: Cell and Gene Therapy Catapult Licenses Cell Culture Data to Ajinomoto Co., Inc.Regulatory news - May 2017Regulatory news - May 2017Gene-modified T-cells: Going into battleGene-modified T-cells: Going into battleHighlights from ISCT 2017Highlights from ISCT 2017Cynata Therapeutics announce first patient treated in Phase I clinical trialCynata Therapeutics announce first patient treated in Phase I clinical trialStem cell therapies: can anything stop them now?Stem cell therapies: can anything stop them now?ReNeuron awarded major UK cell therapy manufacturing grantReNeuron awarded major UK cell therapy manufacturing grantPress release: Novel cell growth and measurement techniques unveiled at ISCT 2017Press release: Novel cell growth and measurement techniques unveiled at ISCT 2017Regulatory news - April 2017Regulatory news - April 2017Updating our clinical trials and preclinical programmes databasesUpdating our clinical trials and preclinical programmes databases